Medicines and Healthcare products Regulatory Agency
Regulatory Agency
- Alerts, recalls and safety information: medicines and medical devices
- Drug Safety Update
- Yellow Card: Report a problem with a medicine or medical device
- Marketing authorisations and licensing guidance
- Product information about medicines
- Regulating medical devices
- Latest information for patients
- About MHRA
- All MHRA services and information
Featured
Press release
MHRA approves imlunestrant tosylate (Inluryo) - a new treatment for breast cancer
As with any medicine, the MHRA will keep the safety and effectiveness of imlunestrant tosylate under close review.
Press release
Brensocatib licensed as the first medicine specifically designed to treat non-cystic fibrosis bronchiectasis in patients 12 years and older
As with any medicine, the MHRA will keep the safety and effectiveness of brensocatib under close review.
News story
MHRA approves zanidatamab (Ziihera) for the treatment of biliary tract cancer
Zanidatamab is used when the cancer cannot be removed by surgery and has spread to nearby tissues or other parts of the body.
Press release
UK medical device testing hits record high as MHRA backs growth in brain and AI technology
Patients benefit from earlier access to technologies that could improve or save lives, as the MHRA approved 17 per cent more clinical investigations in 2025 compared with 2024, and launches measures to support innovation and growth.
News story
MHRA launches a consultation on indefinite recognition of CE-marked medical devices
MHRA launches a consultation on indefinite recognition of CE-marked medical devices
Press release
20 million illegal erectile dysfunction pills seized as MHRA warns against risky online buys
People are urged to avoid risky online buys and protect their health, as the MHRA seizes over 4.4 million doses of unlicensed erectile dysfunction medicines in 2025 alone.
Latest from the Medicines and Healthcare products Regulatory Agency
What we do
The Medicines and Healthcare products Regulatory Agency regulates medicines, medical devices and blood components for transfusion in the UK.
MHRA is an executive agency, sponsored by the Department of Health and Social Care.
Follow us
Documents
Our management
Contact MHRA
General enquiries
10 South Colonnade
London
E14 4PU
United Kingdom
Telephone
020 3080 6000
Fax
020 3118 9803
Office hours are Monday to Friday, 9am to 5pm.
Media enquiries
MHRA10 South Colonnade
London
E14 4PU
United Kingdom
Telephone (including out of hours):
020 3080 7651
Make a Freedom of Information (FOI) request
- Read about the Freedom of Information (FOI) Act and how to make a request.
- Check our previous releases to see if we’ve already answered your question.
- Make a new request by contacting us using the details below.
Freedom of Information
10 South Colonnade
London
E14 4PU
United Kingdom